BLAKE MCLEMORE: Open Payments
NPI 1902515687 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $895 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Viatris Specialty LLC | 2 | $36 |
| United Therapeutics Corporation | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: Prolastin-C Liquid, ACTHAR, GLASSIA, JASCAYD, ZERBAXA, YUPELRI, Tyvaso, OFEV.
Industry payments across AL — which companies pay providers there.
